← Eichor
Condition: Non Resectable Pancreas Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Non Resectable Pancreas Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Phase 2 · 1 location(s) · Fudan University · NCT06359275EUS Procedures Using RIVOS™ EUS Access Device
Phase N/A · 1 location(s) · Orlando Health, Inc. · NCT07696572Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
Phase 2 · 1 location(s) · Morten Ladekarl · NCT05841420Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
Phase N/A · 1 location(s) · Englewood Hospital and Medical Center · NCT06937996Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With P
Phase 1/Phase 2 · 1 location(s) · Smartwise Sweden AB · NCT07575191Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Phase 1/Phase 2 · 3 location(s) · National Cancer Institute (NCI) · NCT05053971Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)
NA · 2 location(s) · Alpha Tau Medical LTD. · NCT05657743Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
Phase 2 · 1 location(s) · University of Pennsylvania · NCT07199764Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
Phase 2 · 1 location(s) · National Cancer Center, Korea · NCT06135896Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
NA · 1 location(s) · Fox Chase Cancer Center · NCT06984562Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alon
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07600268Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NA · 15 location(s) · Alpha Tau Medical LTD. · NCT06698458Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · University of Virginia · NCT06479239Surgery for Locally Unresectable Pancreatic Cancer
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07241663CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06503497Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
Phase 1/Phase 2 · 2 location(s) · Dana-Farber Cancer Institute · NCT04789486Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Phase 2 · 4 location(s) · Proton Collaborative Group · NCT02598349Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.
Phase 4 · 4 location(s) · Hospital Clinico Universitario de Santiago · NCT06099119Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
Phase 2 · 1 location(s) · HealthPartners Institute · NCT06605430Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer
NA · 1 location(s) · Chinese University of Hong Kong · NCT06160323A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT06882746A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded
EARLY_Phase 1 · 1 location(s) · The First Affiliated Hospital of Air Force Medicial Universi · NCT07198659A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly o
Phase 1 · 2 location(s) · Continuity Biosciences, LLC · NCT07481383Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07066995A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors
Phase 1/Phase 2 · 12 location(s) · A2 Biotherapeutics Inc. · NCT06051695Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer
NA · 5 location(s) · Copenhagen University Hospital at Herlev · NCT05788744En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve th
NA · 1 location(s) · Oslo University Hospital · NCT06850753Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced P
Phase 3 · 1 location(s) · Zhejiang Cancer Hospital · NCT07235930
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.